Colorado, et al. v. Airline Tariff Pub. Co.; No. 1:90-CV-2485-MHS and MDL No. 861 (N.D. Georgia) (October 1994)

October 9, 2020

Settlement providing for discounted ticket prices for state and local government agency air travel reached between Plaintiff States and certain airlines over price-fixing scheme.

Read More →

Maryland et al v. Mitsubishi Electronics America; 1992-1 Trade Cas. (CCH) ¶69,743 (D. Md. 1992)

October 9, 2020

Plaintiff States sought damages and injunctive relief, alleging that Mitsubishi Electronics America, Inc. (MELA) conspired with its dealers to set or maintain the resale price of its electronics equipment. In the settlement with Plaintiff States, MELA was enjoined from engaging in the alleged conduct and agreed to pay $6 million dollars for administrative costs and to reimburse qualified buyers.

Read More →

New York et al. v. Matsushita Electric Corp. of America (S.D.N.Y. 1989)

October 9, 2020

Plaintiff States sued for damages and injunctive relief on their own behalf and as parens patriae. The complaint alleged that Defendant conspired to fix or maintain the resale price for which dealers were able to sell Matsushita?s products. The case was settled. Plaintiff States were awarded damages and injunctive relief.

Read More →

Missouri v. American Cyanamid Co.; 1997 U.S. Dist. LEXIS 4722,.1997-1 Trade Cas. (CCH) 71,712 (W.D. MO. 1997)

October 9, 2020

The Plaintiff States alleged that between 1989 and 1995, American Cyanamid Company (American Cyanamid) entered into contracts for Crop Protection Chemicals (CPC), with its dealers in which they agreed formally and in writing to a rebate program that held floor prices at levels equal to Defendant’s wholesale prices for affected CPC.

Read More →

Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL 1410, MDL 1413 (S .D.N.Y.)

October 9, 2020

Plaintiff States sought damages and injunctive relief, alleging that the drug company, Bristol-Myers Squibb, Co. (BMS) wrongfully maintained a monopoly on Taxol, a drug for which the Plaintiff States alleged Defendant fraudulently filed a patent. BMS’s alleged wrongful action delayed entry into the market by generic competitors of the drug, resulting in higher prices for Taxol. In 2008, plaintiff states sued BMS for failing to report accurately to the states, pursuant to the settlemen, a patent arrangement involving the drug Plavix. The company pleaded guilty to lying to the FTC and the states recovered $1.1 million in fines.

Read More →

Florida, et al. v. Nine West Group, Inc. and John Doe, 1-500, 80 F. Supp.2d 181 (S.D.N.Y. 2000); No. 00-CV-1707 (S.D.N.Y. Dec. 14, 2000)

October 9, 2020

Plaintiff States sought damages and injunctive relief, alleging that Nine West Group (Nine West) conspired with unnamed dealers to set the minimum resale price at
which retailers were permitted to sell women’s dress shoes to customers.

Read More →

NAAG Endorses First Step Act

October 7, 2020

As our jurisdictions’ Attorneys General, public safety and the faithful execution of the law fall squarely on our shoulder. Constituents hold us uniquely accountable for ensuring our communities provide a safe place to work and raise a family. To that end, we have supported legislation that strongly punishes criminal conduct while making sure people exiting prison pose less of a threat than when they entered.

Read More →

Social Security Administration Should Implement New Database

October 7, 2020

Consumers in our respective jurisdictions continue to contact us about the growing problem of identity fraud. The fraud comes in various forms and causes various harms, including monetary loss, damage to credit score, and detriment to personal security. As both law enforcement officials and advisors to government agencies, we know the challenges of keeping government systems a step ahead of fraudulent actors. Although the challenge may be great, we urge you to prioritize making your systems as nimble and strong as possible to combat this growing problem.

Read More →

NAAG to Congress: Reauthorize Violence Against Women Act

October 7, 2020

As the legislative history of VAWA has shown, members from both sides of the aisle have come together to strengthen existing protections and fill gaps in the law. We, therefore, urge you to work together as leaders of your respective caucuses and committees to act before VAWA expires and pass a VAWA reauthorization bill that continues to ensure our nation’s most vulnerable victims are not left behind.

Read More →

Colorado ex rel. Weiser v. Unitedhealth Group;

October 2, 2020

UnitedHealth Group sought to acquire the physician practice group of DaVita Inc., which owned two large physician’s’groups in Colorado Springs. UnitedHealthcare is the largest provider of Medicare Advantage plans in the region. The FTC investigated the merger but did not take any action with respect to Colorado. The state filed a complaint in state court aleging that the transaction would give the combined parties the ability to raise their price to other insurance companies that serve Medicare Advantage patients in the Colorado Springs area. The state alleged that the merger would resultin “reduced competition, higher health care costs, reduced benefits and fewer choices for seniors.” The state reached a consent judgment with the parties, under which UnitedHealthcare will lift its exclusive contract with Centura Health for at least 3.5 years, which will expand the network of healthcare providers available to seniors in Medicare Advantage plans offered by other providers. In addition, DaVita Medical Group’s agreement with Humana—UnitedHealthcare’s main competitor in Colorado Springs—will be extended without change through at least the end of 2020 .

Read More →